The United States medical enzymes market is projected to grow with a CAGR of 6.43% during the forecasting period, reaching a revenue share of $2020.87 million by 2028. The base year considered for the studied market is 2021, and the forecasted period is from 2022 to 2028.

UNITED STATES MEDICAL ENZYMES MARKET FORECAST 2022-2028

United States Medical Enzymes Market by Type (Hydrolase (Hyaluronidase, Lysozymes, Other Hydrolases Enzymes), Thrombolytic (Streptokinase, Urokinase, Other Thrombolytic Enzymes), Digestive Enzyme (Lactase, L-asparaginase, Other Digestive Enzymes), Endonuclease (Benzonase, Other Endonucleases)) Market by Application ( Disease Treatment, Diagnostic Tools, Biomedical Research, Other Applications)

Request free sample

The United States medical enzymes market is projected to grow with a CAGR of 6.43% during the forecasting period, reaching a revenue share of $2020.87 million by 2028. The base year considered for the studied market is 2021, and the forecasted period is from 2022 to 2028.

The market growth of the country is primarily credited to technological innovations and developments, increasing consciousness about health and personal care, and extensive research activities associated with medical enzymes.

United States Medical Enzymes Market

To know more about this report, request a free sample copy

In the United States, the consumption of probiotics, particularly through dietary supplements, is high. Moreover, the nation also records a rise in demand for digestive health ingredients on account of the growing health awareness and consciousness. According to the Centre for Medicare and Medicaid Services, the United States national healthcare is estimated to reach nearly $6.2 trillion by the year 2028. Hence, the significant healthcare expenditure, in addition to research and development progressions, is expected to contribute to the adoption and demand for medical enzymes in the United States.

On the other hand, the presence of leading companies and enterprises in the country, along with the partnerships as well as collaborations imitated by them, are set to augment the United States’ market growth. For example, Codexis and Nestle Health Science collaborated to discover newer enzyme therapies for the effective treatment of gastrointestinal (GI) diseases. Besides, Codexis also extended its partnership with Tate and Lyle, a global supplier of food and beverage ingredients, in order to expand business operations in the country. Likewise, while DuPont introduced Enovera 3001, an enzyme-only solution, Codexis launched reverse transcriptase for use in one-step reverse transcription. Hence, such product launches, in addition to the aforementioned factors, are set to proliferate the medical enzymes market growth in the United States during the forecast years.

The United States medical enzymes market is segmented into type and application. The application segment is further categorized into disease treatment, diagnostic tools, biomedical research, and other applications. Biomedical research entails the use of enzymes as therapeutics, biomarkers, and drug targets. It also includes the application of enzymes in biochemistry, enzyme function, enzyme activity, as well as the food industry. The use of enzymes in the diagnosis of biological abnormalities is based on the fact that endogenous enzymes’ activity is highly sensitive to health conditions. Moreover, enzymes are also particularly useful for the detection of changes in substrate concentrations, suggestive of physiological disturbances.

Medical enzymes have various other applications, as well. For instance, enzymes are used for bioanalysis, oncology and thrombus treatment, antibody research, and cell biology. They are utilized in a cell for carrying out chemical reactions rapidly, thereby enabling a cell to build things as required. Enzymes can also be used for coronavirus nucleic acid tests in order to help tackle the disease.

Some of the key companies operating in the United States medical enzymes market include DSM, Novus, Thermo Fisher Scientific, etc.

DSM, headquartered in the United States, is a global company operating in the field of bioscience, nutrition, and health. The company’s key markets include early life nutrition, food and beverage, animal feed, dietary supplements, automotive, electrical and electronics, pharma solutions, and personal care. DSM has over 100 commercial production facilities across 41 nations.

The company’s vitamins are critical for human health and cover a wide range of medical conditions.

Report Synopsis

Report ScopeDetails
Market Forecast Years2022-2028
Base Year2021
Market Historical Years2018-2021
Forecast UnitsRevenue ($ Million)
Segments AnalyzedType and Application
Country AnalyzedUnited States
Companies Analyzed

Codexis, DSM, DuPont, Novozymes, Novus, Thermo Fisher Scientific

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • COUNTRY SNAPSHOT
      • COUNTRY ANALYSIS
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
    3. KEY ANALYTICS
      • IMPACT OF COVID-19 ON MEDICAL ENZYMES MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • PESTLE ANALYSIS – UNITED STATES
      • VALUE CHAIN ANALYSIS
        • RESEARCH AND DEVELOPMENT
        • OPERATIONS
        • OUTBOUND LOGISTICS
      • KEY BUYING CRITERIA
        • COST
        • QUALITY
        • APPLICATION
    1. MARKET BY TYPE
      • HYDROLASE
        • HYALURONIDASE
        • LYSOZYMES
        • OTHER HYDROLASES ENZYMES
      • THROMBOLYTIC
        • STREPTOKINASE
        • UROKINASE
        • OTHER THROMBOLYTIC ENZYMES
      • DIGESTIVE ENZYME
        • LACTASE
        • L-ASPARAGINASE
        • OTHER DIGESTIVE ENZYMES
      • ENDONUCLEASE
        • BENZONASE
        • OTHER ENDONUCLEASES
    1. MARKET BY APPLICATION
      • DISEASE TREATMENT
      • DIAGNOSTIC TOOLS
      • BIOMEDICAL RESEARCH
      • OTHER APPLICATIONS
    2. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS & DIVESTITURES
      • COMPANY PROFILES
        • CODEXIS
        • DSM
        • DUPONT
        • NOVOZYMES
        • NOVUS
        • THERMO FISHER SCIENTIFIC

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – MEDICAL ENZYMES

    TABLE 2: MEDICAL APPLICATION OF VARIOUS ENZYMES

    TABLE 3: APPLICATIONS OF ENZYMES IN PHARMACEUTICALS INDUSTRY

    TABLE 4: UNITED STATES MEDICAL ENZYMES MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 5: UNITED STATES MEDICAL ENZYMES MARKET, BY TYPE, FORECAST YEARS, 2022-2028 (IN $ MILLION)

    TABLE 6: UNITED STATES MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 7: UNITED STATES MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, FORECAST YEARS, 2022-2028 (IN $ MILLION)

    TABLE 8: UNITED STATES MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 9: UNITED STATES MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, FORECAST YEARS, 2022-2028 (IN $ MILLION)

    TABLE 10: UNITED STATES MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 11: UNITED STATES MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, FORECAST YEARS, 2022-2028 (IN $ MILLION)

    TABLE 12: UNITED STATES MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 13: UNITED STATES MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, FORECAST YEARS, 2022-2028 (IN $ MILLION)

    TABLE 14: UNITED STATES MEDICAL ENZYMES MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 15: UNITED STATES MEDICAL ENZYMES MARKET, BY APPLICATION, FORECAST YEARS, 2022-2028 (IN $ MILLION)

    TABLE 16: LIST OF MERGERS & ACQUISITIONS

    TABLE 17: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 18: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 19: LIST OF BUSINESS EXPANSIONS & DIVESTITURES          

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: PESTLE ANALYSIS

    FIGURE 5: VALUE CHAIN ANALYSIS

    FIGURE 6: KEY BUYING CRITERIA

    FIGURE 7: UNITED STATES MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021

    FIGURE 8: UNITED STATES MEDICAL ENZYMES MARKET, BY HYDROLASE, 2022-2028 (IN $ MILLION)

    FIGURE 9: UNITED STATES MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY HYDROLASE ENZYME, IN 2021

    FIGURE 10: UNITED STATES MEDICAL ENZYMES MARKET, BY HYALURONIDASE, 2022-2028 (IN $ MILLION)

    FIGURE 11: UNITED STATES MEDICAL ENZYMES MARKET, BY LYSOZYMES, 2022-2028 (IN $ MILLION)

    FIGURE 12: UNITED STATES MEDICAL ENZYMES MARKET, BY OTHER HYDROLASES ENZYMES, 2022-2028 (IN $ MILLION)

    FIGURE 13: UNITED STATES MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYMES, 2022-2028 (IN $ MILLION)

    FIGURE 14: UNITED STATES MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY THROMBOLYTIC ENZYME, IN 2021

    FIGURE 15: UNITED STATES MEDICAL ENZYMES MARKET, BY STREPTOKINASE, 2022-2028 (IN $ MILLION)

    FIGURE 16: UNITED STATES MEDICAL ENZYMES MARKET, BY UROKINASE, 2022-2028 (IN $ MILLION)

    FIGURE 17: UNITED STATES MEDICAL ENZYMES MARKET, BY OTHER THROMBOLYTIC ENZYMES, 2022-2028 (IN $ MILLION)

    FIGURE 18: UNITED STATES MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)

    FIGURE 19: UNITED STATES MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY DIGESTIVE ENZYME, IN 2021

    FIGURE 20: UNITED STATES MEDICAL ENZYMES MARKET, BY LACTASE, 2022-2028 (IN $ MILLION)

    FIGURE 21: UNITED STATES MEDICAL ENZYMES MARKET, BY L-ASPARAGINASE, 2022-2028 (IN $ MILLION)

    FIGURE 22: UNITED STATES MEDICAL ENZYMES MARKET, BY OTHER DIGESTIVE ENZYMES, 2022-2028 (IN $ MILLION)

    FIGURE 23: UNITED STATES MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2028 (IN $ MILLION)

    FIGURE 24: UNITED STATES MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY ENDONUCLEASE, IN 2021

    FIGURE 25: UNITED STATES MEDICAL ENZYMES MARKET, BY BENZONASE, 2022-2028 (IN $ MILLION)

    FIGURE 26: UNITED STATES MEDICAL ENZYMES MARKET, BY OTHER ENDONUCLEASES, 2022-2028 (IN $ MILLION)

    FIGURE 27: UNITED STATES MEDICAL ENZYMES MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021

    FIGURE 28: UNITED STATES MEDICAL ENZYMES MARKET, BY DISEASE TREATMENT, 2022-2028 (IN $ MILLION)

    FIGURE 29: UNITED STATES MEDICAL ENZYMES MARKET, BY DIAGNOSTIC TOOLS, 2022-2028 (IN $ MILLION)

    FIGURE 30: UNITED STATES MEDICAL ENZYMES MARKET, BY BIOMEDICAL RESEARCH, 2022-2028 (IN $ MILLION)

    FIGURE 31: UNITED STATES MEDICAL ENZYMES MARKET, BY OTHER APPLICATIONS, 2022-2028 (IN $ MILLION)       

    1. MARKET BY TYPE
      • HYDROLASE
        • HYALURONIDASE
        • LYSOZYMES
        • OTHER HYDROLASES ENZYMES
      • THROMBOLYTIC
        • STREPTOKINASE
        • UROKINASE
        • OTHER THROMBOLYTIC ENZYMES
      • DIGESTIVE ENZYME
        • LACTASE
        • L-ASPARAGINASE
        • OTHER DIGESTIVE ENZYMES
      • ENDONUCLEASE
        • BENZONASE
        • OTHER ENDONUCLEASES
    1. MARKET BY APPLICATION
      • DISEASE TREATMENT
      • DIAGNOSTIC TOOLS
      • BIOMEDICAL RESEARCH
      • OTHER APPLICATIONS

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type